Drug profile

The FDA adverse-event record for Appetite Stimulant

22 adverse-event reports submitted to the FDA Center for Veterinary Medicine reference Appetite Stimulant. See the species affected, top reactions, and outcomes below.

22
adverse-event reports
45.5%
death-coded share
Dog
most-reported species
8
Lethargy (see also Central nervous system depression in Neurological) - top reaction
Verify with FDA CVM →
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
22
Total Reports
10
Deaths Reported
45.5%
Death Rate

Active Ingredients

Appetite Stimulant

Administration Routes

UnknownOralAuricular (Otic)Topical

Species Affected

Dog 14
Cat 8

Most Affected Breeds

Domestic Shorthair 3
Chihuahua 2
Siberian Husky 2
Ragdoll 2
Poodle (unspecified) 2
Oriental 1
Crossbred Canine/dog 1
Deutsche Dogge, Great Dane 1
Pointing Dog - German Short-haired 1
Domestic Longhair 1

Most Reported Reactions

Lethargy (see also Central nervous system depression in Neurological) 8
Anorexia 7
Diarrhoea 7
Death by euthanasia 7
Weight loss 6
Vomiting 6
Ataxia 4
Decreased appetite 4
Not eating 4
Panting 4
Lethargy (see also Central nervous system depression in 'Neurological') 3
Limb weakness 3

Outcome Breakdown

Euthanized
7 (31.8%)
Ongoing
5 (22.7%)
Recovered/Normal
5 (22.7%)
Died
3 (13.6%)
Outcome Unknown
2 (9.1%)

Appetite Stimulant Adverse Event Insights

22 reports name Appetite Stimulant; 10 recorded a death outcome (45.5% of reported events, not a population-level mortality rate). Active ingredient: Appetite Stimulant. Administration routes: Unknown, Oral, Auricular (Otic), Topical.

By species: Dog (14 reports), Cat (8 reports). By breed: Domestic Shorthair (3), Chihuahua (2), Siberian Husky (2).

Leading clinical signs: Lethargy (see also Central nervous system depression in Neurological) (8), Anorexia (7), Diarrhoea (7), Death by euthanasia (7). Outcome, 22 coded reports: Euthanized leads at 31.8%.

Read these counts as reporting volume, not risk: per our methodology, a widely-prescribed drug will rack up more raw FDA reports in a given year than a rarely-used one at an identical true rate, so we recommend comparing within similar-exposure products rather than across the full 2025 catalog.

Source: FDA Center for Veterinary Medicine openFDA Animal & Veterinary Adverse Events (CVM AER) · 2025

Every figure on PlainBreed is rendered directly from FDA openFDA adverse event data, no number is typed in by an editor. This page draws directly on FDA openFDA data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.